Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: A prospective validation study
- PMID: 29798957
- DOI: 10.4103/ijc.IJC_306_17
Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: A prospective validation study
Abstract
Objective: The objective of this study was to evaluate the safety and efficacy of laparoscopy in detecting inoperable disease in patients undergoing interval cytoreduction (ICR) for advanced ovarian carcinoma (AOC). The primary outcome measured was the performance of laparoscopy-based predictive index value (PIV) score developed by Fagotti et al. The secondary outcomes measured were performance of individual parameters included in PIV score and optimal cytoreduction (OCR) rates in our population.
Patients and methods: This is a single-arm, prospective validation trial. Patients undergoing ICR for AOC in our institution were evaluated prospectively with laparoscopy before planned attempt at debulking surgery. Seven laparoscopic parameters included in laparoscopic PIV score were evaluated. Laparoscopic findings were compared with the final outcomes of definitive surgery. OCR was defined as residual disease <1 cm. The efficiency of the individual laparoscopy score was analyzed using receiver operating characteristic (ROC) curves.
Results: A total of 73 patients planned for ICR for AEOC were included in the study. Laparoscopic PIV score could successfully predict inoperability in 12 (16.4% of total study population) out of 14 inoperable patients in the total population and thus could avoid 85% of unsuccessful surgeries at a PIV score cutoff of ≥8. Performance of individual parameters included in PIV score was also evaluated. Two parameters out of seven, that is, mesenteric retraction and stomach infiltration had poor performance on ROC curve. Modified PIV score was calculated for each patient after excluding these two parameters. Modified PIV score had similar performance as Fagotti's PIV score at cutoff ≥6 (P = 0.728, for difference in area under the curve). No staging laparoscopy-related serious adverse events were noted in any of the patients.
Conclusions: Laparoscopy is a safe, effective, and accurate method for predicting inoperability in patients undergoing ICR for AEOC.
Keywords: Carcinoma ovary; diagnostic laparoscopy; interval cytoreduction; ovarian neoplasm.
Conflict of interest statement
There are no conflicts of interest
Similar articles
-
CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer.Korean J Radiol. 2021 Sep;22(9):1481-1489. doi: 10.3348/kjr.2020.1477. Epub 2021 May 26. Korean J Radiol. 2021. PMID: 34132077 Free PMC article.
-
Prediction of nonresectability using the updated Predictive Index value model assessed by imaging and surgery in tubo-ovarian cancer: a prospective multicenter ISAAC study.Am J Obstet Gynecol. 2024 Dec;231(6):632.e1-632.e14. doi: 10.1016/j.ajog.2024.06.047. Epub 2024 Jul 3. Am J Obstet Gynecol. 2024. PMID: 38969200
-
Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.Am J Obstet Gynecol. 2008 Dec;199(6):642.e1-6. doi: 10.1016/j.ajog.2008.06.052. Epub 2008 Sep 17. Am J Obstet Gynecol. 2008. PMID: 18801470
-
Role of minimally invasive surgery in ovarian cancer.J Minim Invasive Gynecol. 2013 Nov-Dec;20(6):754-65. doi: 10.1016/j.jmig.2013.04.027. J Minim Invasive Gynecol. 2013. PMID: 24183269 Review.
-
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature.Minerva Med. 2019 Aug;110(4):341-357. doi: 10.23736/S0026-4806.19.06132-9. Epub 2019 May 22. Minerva Med. 2019. PMID: 31124636
Cited by
-
Neglected Anatomical Areas in Ovarian Cancer: Significance for Optimal Debulking Surgery.Cancers (Basel). 2024 Jan 9;16(2):285. doi: 10.3390/cancers16020285. Cancers (Basel). 2024. PMID: 38254777 Free PMC article. Review.
-
Ovarian Cancer Staging-How CT Scan Descriptions Differ from Surgical Findings.J Clin Med. 2024 Aug 5;13(15):4560. doi: 10.3390/jcm13154560. J Clin Med. 2024. PMID: 39124826 Free PMC article.
-
Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction.Diagnostics (Basel). 2020 Aug 7;10(8):568. doi: 10.3390/diagnostics10080568. Diagnostics (Basel). 2020. PMID: 32784719 Free PMC article. Review.
-
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.J Clin Oncol. 2025 Mar;43(7):868-891. doi: 10.1200/JCO-24-02589. Epub 2025 Jan 22. J Clin Oncol. 2025. PMID: 39841949 Free PMC article.
-
Assessment of Intraoperative Scoring Systems for Predicting Cytoreduction Outcome in Peritoneal Metastatic Disease: A Systematic Review and Meta-analysis.Ann Surg Oncol. 2024 Oct;31(10):7165-7183. doi: 10.1245/s10434-024-15629-7. Epub 2024 Jun 25. Ann Surg Oncol. 2024. PMID: 38918326
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical